10-K Filing

Silo Pharma, Inc. CIK: 1514183 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0001213900-23-022813`
Period End Date	20221231
Filing Date	20230324
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	f10k2022_silopharma_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 63 Income Statement 67 Cash Flow Statement 66 Stockholders Equity 17

Balance Sheet 63 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.37M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.84M	USD	Point-in-time
Equity investments	`EquityInvestmentsAtCost`	$420.00K	USD	Point-in-time
Equity investments	`EquityInvestmentsAtCost`	$3.12K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$145.32K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$135.89K	USD	Point-in-time
Note receivable, including interest receivable of $6,010 at December 31, 2022	`AccountsAndOtherReceivablesNetCurrent`	-	USD	Point-in-time
Note receivable, including interest receivable of $6,010 at December 31, 2022	`AccountsAndOtherReceivablesNetCurrent`	$66.01K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$11.57M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$10.40M	USD	Point-in-time
Note receivable - non-current, including interest receivable of $1,210 at December 31, 2021	`NoteReceivableNoncurrentIncludingInterestReceivable`	-	USD	Point-in-time
Note receivable - non-current, including interest receivable of $1,210 at December 31, 2021	`NoteReceivableNoncurrentIncludingInterestReceivable`	$61.21K	USD	Point-in-time
Interest receivable current (in Dollars)	`InterestReceivableCurrent`	$6.01K	USD	Point-in-time
Prepaid expenses and other assets - non-current	`PrepaidExpenseNoncurrent`	$26.66K	USD	Point-in-time
Prepaid expenses and other assets - non-current	`PrepaidExpenseNoncurrent`	$70.82K	USD	Point-in-time
Total Assets	`Assets`	$10.49M	USD	Point-in-time
Interest receivable non-current (in Dollars)	`InterestReceivableNoncurrent`	$1.21K	USD	Point-in-time
Total Assets	`Assets`	$11.64M	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts payable and accrued expenses	`LoansPayableCurrent`	$364.22K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Accounts payable and accrued expenses	`LoansPayableCurrent`	$417.94K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Deferred revenue - current portion	`DeferredRevenueCurrent`	$72.10K	USD	Point-in-time
Deferred revenue - current portion	`DeferredRevenueCurrent`	$72.10K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$436.32K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$490.04K	USD	Point-in-time
Deferred revenue - long-term portion	`DeferredRevenueNoncurrent`	$937.88K	USD	Point-in-time
Deferred revenue - long-term portion	`DeferredRevenueNoncurrent`	$865.78K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	$937.88K	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	$865.78K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Total Liabilities	`Liabilities`	$1.30M	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.43M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	1.97M	shares	Point-in-time
Commitment and Contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	3.16M	shares	Point-in-time
Commitment and Contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	1.97M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	3.16M	shares	Point-in-time
Preferred stock, $0.0001 par value, 5,000,000 shares authorized:	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 5,000,000 shares authorized:	`PreferredStockValue`	-	USD	Point-in-time
Series A redeemable convertible preferred stock, $0.0001 par value, 1,000,000 shares designated; no shares issued and outstanding at December 31, 2022 and 2021 ($100 per share redemption value)	`ConvertiblePreferredStockValueIssued2`	-	USD	Point-in-time
Series A redeemable convertible preferred stock, $0.0001 par value, 1,000,000 shares designated; no shares issued and outstanding at December 31, 2022 and 2021 ($100 per share redemption value)	`ConvertiblePreferredStockValueIssued2`	-	USD	Point-in-time
Series B convertible preferred stock, $0.0001 par value, 2,000 shares designated; no shares issued and outstanding at December 31, 2022 and 2021 ($1,000 per share liquidation value)	`ConvertiblePreferredStockValueIssued`	-	USD	Point-in-time
Series B convertible preferred stock, $0.0001 par value, 2,000 shares designated; no shares issued and outstanding at December 31, 2022 and 2021 ($1,000 per share liquidation value)	`ConvertiblePreferredStockValueIssued`	-	USD	Point-in-time
Series C convertible preferred stock, $0.0001 par value, 4,280 shares designated; 0 and 227 shares issued and and outstanding at December 31, 2022 and 2021, respectively ($1,000 per share liquidation value)	`ConvertiblePreferredStockValueIssued1`	-	USD	Point-in-time
Series C convertible preferred stock, $0.0001 par value, 4,280 shares designated; 0 and 227 shares issued and and outstanding at December 31, 2022 and 2021, respectively ($1,000 per share liquidation value)	`ConvertiblePreferredStockValueIssued1`	-	USD	Point-in-time
Common stock, $0.0001 par value, 500,000,000 shares authorized; 3,158,797 and 1,972,739 shares issued and outstanding at December 31, 2022 and 2021, respectively	`CommonStockValue`	$197.00	USD	Point-in-time
Common stock, $0.0001 par value, 500,000,000 shares authorized; 3,158,797 and 1,972,739 shares issued and outstanding at December 31, 2022 and 2021, respectively	`CommonStockValue`	$316.00	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$17.51M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$12.32M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-3.26M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-7.17M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$10.34M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$9.06M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$1.28M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$11.64M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$10.49M	USD	Point-in-time

Income Statement 67 line items

Line Item	Tag	Value	Unit	Period
LICENSE FEE REVENUES:	`LicenseFees`	$71.26K	USD	Annual
LICENSE FEE REVENUES:	`LicenseFees`	$72.10K	USD	Annual
COST OF REVENUES	`CostOfRevenue`	$5.00K	USD	Annual
COST OF REVENUES	`CostOfRevenue`	$5.84K	USD	Annual
GROSS PROFIT	`GrossProfit`	$66.26K	USD	Annual
GROSS PROFIT	`GrossProfit`	$66.26K	USD	Annual
Compensation expense	`ShareBasedCompensation`	$395.12K	USD	Annual
Compensation expense	`ShareBasedCompensation`	$577.65K	USD	Annual
Professional fees	`ProfessionalFees`	$1.60M	USD	Annual
Professional fees	`ProfessionalFees`	$1.50M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$1.29M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$693.91K	USD	Annual
Insurance expense	`GeneralInsuranceExpense`	$108.75K	USD	Annual
Insurance expense	`GeneralInsuranceExpense`	$125.89K	USD	Annual
Bad debt recovery	`ProvisionForDoubtfulAccounts`	$196.50K	USD	Point-in-time
Bad debt recovery	`ProvisionForDoubtfulAccounts`	$-20.00K	USD	Annual
Bad debt recovery	`ProvisionForDoubtfulAccounts`	$-148.50K	USD	Annual
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$227.26K	USD	Annual
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$162.95K	USD	Annual
Total operating expenses	`OperatingExpenses`	$3.69M	USD	Annual
Total operating expenses	`OperatingExpenses`	$2.81M	USD	Annual
LOSS FROM CONTINUING OPERATIONS	`OperatingIncomeLoss`	$-3.63M	USD	Annual
LOSS FROM CONTINUING OPERATIONS	`OperatingIncomeLoss`	$-2.74M	USD	Annual
Interest and dividend income (expense), net	`InterestAndDividendIncomeOperating`	$72.64K	USD	Annual
Interest and dividend income (expense), net	`InterestAndDividendIncomeOperating`	$1.21K	USD	Annual
Other income from equity shares earned for lock up agreement	`OtherIncome`	$85.73K	USD	Annual
Other income from equity shares earned for lock up agreement	`OtherIncome`	-	USD	Annual
Gain on forgiveness of PPP note payable	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Gain on forgiveness of PPP note payable	`GainsLossesOnExtinguishmentOfDebt`	$19.08K	USD	Annual
Interest expense	`InterestExpense`	$2.20K	USD	Annual
Interest expense	`InterestExpense`	$3.04K	USD	Annual
Net realized gain (loss) on equity investments	`GainLossOnInvestments`	$-104.70K	USD	Annual
Net realized gain (loss) on equity investments	`GainLossOnInvestments`	$6.66M	USD	Annual
Net unrealized (loss) gain on equity investments	`UnrealizedGainLossOnEquityInvestments`	$248.59K	USD	Annual
Net unrealized (loss) gain on equity investments	`UnrealizedGainLossOnEquityInvestments`	$-331.20K	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$6.93M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$-279.73K	USD	Annual
(LOSS) INCOME FROM CONTINUING OPERATIONS BEFORE PROVISION FOR INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.18M	USD	Annual
(LOSS) INCOME FROM CONTINUING OPERATIONS BEFORE PROVISION FOR INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.91M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$24.88K	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
(LOSS) INCOME FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperations`	$4.16M	USD	Annual
(LOSS) INCOME FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperations`	$-3.91M	USD	Annual
Gain from sale of assets of discontinued operations, net of tax	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$1.55K	USD	Annual
Gain from sale of assets of discontinued operations, net of tax	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	-	USD	Annual
Loss from discontinued operations, net of tax	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-1.16K	USD	Annual
Loss from discontinued operations, net of tax	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-254.92K	USD	Annual
LOSS FROM DISCONTINUED OPERATIONS	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-253.37K	USD	Annual
LOSS FROM DISCONTINUED OPERATIONS	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-1.16K	USD	Annual
NET (LOSS) INCOME	`NetIncomeLoss`	$-3.91M	USD	Annual
NET (LOSS) INCOME	`NetIncomeLoss`	$3.90M	USD	Annual
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	-	USD	Annual
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	$1.40M	USD	Annual
NET (LOSS) INCOME AVAILABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-3.91M	USD	Annual
NET (LOSS) INCOME AVAILABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$2.50M	USD	Annual
Continuing operations - basic (in Dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.45	USD	Annual
Continuing operations - basic (in Dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.71	USD	Annual
Continuing operations - diluted (in Dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.43	USD	Annual
Continuing operations - diluted (in Dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.71	USD	Annual
Discontinued operations - basic (in Dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.13	USD	Annual
Discontinued operations - basic (in Dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	Annual
Discontinued operations - diluted (in Dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	Annual
Discontinued operations - diluted (in Dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.13	USD	Annual
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	2.28M	shares	Annual
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.90M	shares	Annual
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.92M	shares	Annual
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	2.28M	shares	Annual

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.91M	USD	Annual
Net loss	`NetIncomeLoss`	$3.90M	USD	Annual
Bad debt recovery	`ProvisionForDoubtfulAccounts`	$196.50K	USD	Point-in-time
Bad debt recovery	`ProvisionForDoubtfulAccounts`	$-20.00K	USD	Annual
Bad debt recovery	`ProvisionForDoubtfulAccounts`	$-148.50K	USD	Annual
Stock-based compensation and professional fees	`EmployeeBenefitsAndShareBasedCompensation`	$83.73K	USD	Annual
Stock-based compensation and professional fees	`EmployeeBenefitsAndShareBasedCompensation`	$156.05K	USD	Annual
Amortization of prepaid stock-based professional fees	`AmortizationOfPrepaidStockbasedExpense`	-	USD	Annual
Amortization of prepaid stock-based professional fees	`AmortizationOfPrepaidStockbasedExpense`	$107.97K	USD	Annual
Net realized loss (gain) on equity investments	`IncomeLossFromEquityMethodInvestments`	$6.66M	USD	Annual
Net realized loss (gain) on equity investments	`IncomeLossFromEquityMethodInvestments`	$-104.70K	USD	Annual
Net unrealized loss (gain) loss on equity investments	`UnrealizedGainLossOnInvestments`	$248.59K	USD	Annual
Net unrealized loss (gain) loss on equity investments	`UnrealizedGainLossOnInvestments`	$-331.20K	USD	Annual
Equity shares earned for lock up agreement	`EquitySharesEarnedForServices`	$-85.73K	USD	Annual
Equity shares earned for lock up agreement	`EquitySharesEarnedForServices`	-	USD	Annual
Gain on forgiveness of PPP note payable and accrued interest	`GainsLossesOnRestructuringOfDebt`	$19.08K	USD	Annual
Gain on forgiveness of PPP note payable and accrued interest	`GainsLossesOnRestructuringOfDebt`	-	USD	Annual
Gain from disposal of assets from discontinued operations	`GainLossOnDispositionOfAssets`	$1.55K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$38.86K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$-55.34K	USD	Annual
Assets of discontinued operations	`IncreaseDecreaseInAssetsOfDiscontinuedOperation`	-	USD	Annual
Assets of discontinued operations	`IncreaseDecreaseInAssetsOfDiscontinuedOperation`	$-24.96K	USD	Annual
Interest receivable	`IncreaseDecreaseInReceivables`	$1.21K	USD	Annual
Interest receivable	`IncreaseDecreaseInReceivables`	$4.80K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-53.72K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$291.05K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$478.74K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-72.10K	USD	Annual
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-2.28M	USD	Annual
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-3.50M	USD	Annual
Net proceeds from sale of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	$7.02M	USD	Annual
Net proceeds from sale of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	$66.71K	USD	Annual
Collection on note receivable written off prior to 2019	`ProceedsFromCollectionOfNotesReceivable`	-	USD	Annual
Collection on note receivable written off prior to 2019	`ProceedsFromCollectionOfNotesReceivable`	$7.50K	USD	Annual
Collection on note receivable	`CollectionOnNoteReceivable`	$20.00K	USD	Annual
Collection on note receivable	`CollectionOnNoteReceivable`	$164.50K	USD	Annual
NET CASH PROVIDED BY INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$86.71K	USD	Annual
NET CASH PROVIDED BY INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$7.19M	USD	Annual
Net proceeds from sale of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	-	USD	Annual
Net proceeds from sale of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$3.79M	USD	Annual
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$4.94M	USD	Annual
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Advance from a related party	`AdvanceFromARelatedParty`	-	USD	Annual
Advance from a related party	`AdvanceFromARelatedParty`	$2.37K	USD	Annual
Repayment of advance from a related party	`RepaymentsOfRelatedPartyDebt`	-	USD	Annual
Repayment of advance from a related party	`RepaymentsOfRelatedPartyDebt`	$2.37K	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$4.94M	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$3.79M	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS:	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$1.53M	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS:	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$8.71M	USD	Annual
CASH AND CASH EQUIVALENTS - beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.84M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.37M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.13M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.84M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.37M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.13M	USD	Point-in-time
Interest	`InterestPaidNet`	-	USD	Annual
Interest	`InterestPaidNet`	$2.20K	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	$25.16K	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	-	USD	Annual
Increase in equity investments recorded as deferred revenue pursuant to a patent license agreement	`IncreaseInEquityInvestmentsRecordedAsDeferredRevenuePursuantToAPatentLicenseAgree`	$531.25K	USD	Annual
Increase in equity investments recorded as deferred revenue pursuant to a patent license agreement	`IncreaseInEquityInvestmentsRecordedAsDeferredRevenuePursuantToAPatentLicenseAgree`	-	USD	Annual
Note receivable issued in connection with asset purchase agreement	`NoteReceivableIssuedInConnectionWithAssetPurchaseAgreement`	$60.00K	USD	Annual
Note receivable issued in connection with asset purchase agreement	`NoteReceivableIssuedInConnectionWithAssetPurchaseAgreement`	-	USD	Annual
Common stock issued for future services	`CommonStockIssuedForFutureServices`	$135.10K	USD	Annual
Common stock issued for future services	`CommonStockIssuedForFutureServices`	-	USD	Annual

Stockholders Equity 17 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$10.34M	USD	Point-in-time
Balance	`StockholdersEquity`	$9.06M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.28M	USD	Point-in-time
Series C preferred stock issued for cash, net of offering cost	`StockIssuedDuringPeriodValueOther`	$3.79M	USD	Annual
Deemed dividend upon issuance of preferred stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	-	USD	Annual
Common stock warrants granted for services	`StockIssuedDuringPeriodValueIssuedForServices`	$83.73K	USD	Annual
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$4.94M	USD	Annual
Accretion of stock options expense to stock based compensation	`AmortizationOfPrepaidStockbasedCompensation`	$111.01K	USD	Annual
Common shares issued for professional fees	`StockIssuedDuringPeriodValueCommonSharesIssuedForProfessionalFees`	$135.10K	USD	Annual
Common stock issued for conversion of Series C preferred stock	`CommonStockIssuedForConversionOfSeriesCPreferredStock`	-	USD	Annual
Common stock issued for conversion of Series C preferred stock	`CommonStockIssuedForConversionOfSeriesCPreferredStock`	-	USD	Annual
Rounding of share due to reverse stock split	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-3.91M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$3.90M	USD	Annual
Balance	`StockholdersEquity`	$10.34M	USD	Point-in-time
Balance	`StockholdersEquity`	$9.06M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.28M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.